The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells

E-ISSN： 1365-2141|170|2|236-246

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.2, 2015-07, pp. : 236-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deferasirox: a novel, once-daily oral iron chelator

By Cappellini Maria Domenica

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 453-460

Future Medicine

Access to resources Recommend Favorite

Antifibrotic activity of deferasirox

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 638-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Oral Iron Chelator Deferasirox Induces Apoptosis in Myeloid Leukemia Cells by Targeting Caspase

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 241-245

Karger

Access to resources Recommend Favorite

Haematopoietic Stem and Progenitor Cells: Enumeration, Phenotypic Characterisation, and Clinical Applications

Transfusion Medicine and Hemotherapy, Vol. 31, Iss. 5, 2004-10 ,pp. : 341-352

Karger

Access to resources Recommend Favorite

Infusion of endothelial progenitor cells ameliorates liver injury in mice after haematopoietic stem cell transplantation

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2611-2620

John Wiley & Sons Inc

Access to resources Recommend Favorite